Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App





Seegene Unveils "$12 PCR Testing" Global Initiative to Help End COVID-19 Pandemic

By LabMedica International staff writers
Posted on 26 May 2022

There have been reports of an uptick in influenza and everyday colds which had been absent during the two-year pandemic, as countries worldwide ease social distancing restrictions and lift mask mandates. More...

Experts have also warned that potentially dangerous mutations could go unnoticed due to scaled down PCR testing with governments no longer providing them for free. Individuals are now required to monitor their health at their own expense to stay safe. Now, a global initiative for preemptive and routine PCR testing aims to help individuals stay safe and healthy while living in the COVID-19 era.

Seegene, Inc. (Seoul, Korea) has unveiled the initiative designed to help people safely return to normalcy and contribute to global efforts to terminate COVID-19 and prevent future outbreaks. Seegene's initiative dubbed 'In-life PCR,' entails asymptomatic testing for early virus detection, syndromic respiratory testing as anti-virus restrictions are eased, and boosting PCR test accessibility through affordable pricing. PCR tests can identify infected people with mild or even no symptoms. Regular asymptomatic testing, even without doctor's prescription, is expected to help curb widespread infections at community facilities, such as schools, churches, or nursing homes and ensure safe return to normal life.

Syndromic testing is crucial for determining which virus is responsible for a person's symptoms and what treatment makes sense. Seegene will provide its Allplex SARS-CoV-2 FluA/FluB/RSV Assay, which can simultaneously detect SARS-CoV-2 (via the N, RdRP and S gene), influenza A and B, and RSV (A/B). The WHO recommends the screening of at least two target genes for SARS-CoV-2. Seegene's assay identifies three to maintain detection accuracy if new COVID-19 variants emerge. The six-target assay also includes two internal controls for added accuracy. Seegene will work with hospitals and labs so that a test can cost around US$12 to boost accessibility and encourage routine testing. High multiplex technologies that build upon the company's 20+ years of expertise in molecular diagnostics have enabled Seegene to lower the barrier to access.

"The '$12 PCR testing' campaign is expected to help Seegene deliver its commitment to making molecular diagnostics accessible to anyone," said Dr. Jong-Yoon Chun, CEO of Seegene. "I'm certain that routine PCR testing will be the best solution to help end the COVID-19 pandemic. Seegene will provide full support for cities or countries that join hands with us to better track and curb the outbreak."

Related Links:
Seegene, Inc. 


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Collection and Transport System
PurSafe Plus®
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: Erythrocyte Sedimentation Rate Sample Stability (Photo courtesy of ALCOR Scientific)

ESR Testing Breakthrough Extends Blood Sample Stability from 4 to 28 Hours

Erythrocyte sedimentation rate (ESR) is one of the most widely ordered blood tests worldwide, helping clinicians detect and monitor infections, autoimmune conditions, cancers, and other diseases.... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.